Avery Dennison Medical Solutions Demonstrates the Efficacy of Its New Chlorhexidine Gluconate Adhesive Delivery System
Tests conducted by an independent laboratory for Avery Dennison Medical Solutions, a division of Avery Dennison Corporation (NYSE: AVY) confirms that the new Avery Dennison Medical Solutions Chlorhexidine Gluconate adhesive delivery system provides antimicrobial efficacy across a broad range of bacteria and yeast.
These data demonstrate that the challenge of incorporating CHG within a solvent acrylic adhesive has been successfully addressed.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
